The cyclin-dependent kinase inhibitor 2A (CDKN2a) locus—frequently mutated or deleted in human cancer—encodes two different tumor suppressors, INK4a (referred to as p16INK4a) and ARF (referred to as p14ARF in humans and p19ARF in mice) [1,2]. Here, CDKN2A is linked to neoplasm.